主な学術論文・総説
2018（平成 30）年
Matsuda C. et al.,Quantification of CSF cystatin C using liquid chromatography tandem mass
spectrometry. Clin. Chim. Acta 478, 1-6, 2018.

2017（平成 29）年
Suehiro S. et al.,Polymer-coated cardiopulmonary bypass circuit attenuates upregulation of bothproteases/protease inhibitors and platelet degranulation in pigs. Perfusion 32, 645-655,
2017.
Sakai T. et al.,A potential contribution of tenascin-X to blood vessel formation in peripheral nerves.
Neurosci. Res., 124, 1-7, 2017.
Yamaguchi S. et al.,Suppression of hepatic dysfunction in tenascin-X-deficient mice fed a high-fat diet. Mol.
Med. Rep. 16, 4061-4067, 2017.

2016（平成 28）年
Yamada, K. et al.
A method for quantification of serum tenascin-X by nano-LC/MS/MS. Clin. Chim. Acta
459, 94-100, 2016.
Oda, T. et al.
Proteomic analysis in cardiovascular research. Surg. Today, 46, 285-296, 2016.
1

Watanabe, A. et al.
Proteomic analysis for the identification of serum diagnostic biomarkers for joint
hypermobility syndrome. Int. J. Mol. Med. 37, 461-467, 2016.
Kobayashi-Miura, K. et al.
Rat articular cartilages change their tissue and protein compositions during perinatal
period. Anat. Histol. Embryol., 45, 9-18, 2016.

2015（平成 27）年
Oda, T. et al.
Does the rewarmed heart restore myocardial proteome to that of the precooling state?
-A proteomic analysis of surgical samples-. Circ. J. 79, 2648-2658, 2015.
Satoh, K. et al.
Monitoring of serial presurgical and postsurgical changes in the serum proteome in aseries of patients with calcific aortic stenosis. Dis. Markers, Volume 2015, Article
ID 694120, 11 pages, 2015.
Sakiyama, T. et al.
Recurrent gastrointestinal perforation in a patient with Ehlers–Danlos syndrome due totenascin-X deficiency. J. Dermatol. 42, 511-514, 2015.
呉姝嫻ら．
発現差異プロテオミクス解析によるマンゴー種子脂質成分の持つ新たな生理活性の検討. 応用薬理研究会, 応用薬理, Pharmacometrics 88 (3/4), 57-65, 2015.
松本健一．
石灰化大動脈弁組織におけるテネイシン X.
ル社, 25, 77-86, 2015.

2CLINICAL CALCIUM, 医薬ジャーナ

2014（平成 26）年
Oda, T. et al.
Plasma proteomic changes during hypothermic and normothermic cardiopulmonary
bypass in aortic surgeries. Int. J. Mol. Med. 34, 947-956, 2014.
Matsumoto, K. et al.
Proteomic comparison between abdominal and thoracic aortic aneurysms. Int. J. Mol.
Med. 33, 1035-1047, 2014.
Kobayashi, M. et al.
Absence of BRINP1 in mice causes increase of hippocampal neurogenesis andbehavioral alterations relevant to human psychiatric disorders. Molecular Brain 7,
article 12, 16 pages, 2014.
松本健一．
エーラス・ダンロス症候群とテネイシン X.

医学のあゆみ, 医歯薬出版株式会社, 248, 507-513, 2014.

2013（平成 25）年
Satoh, K. et al.
Proteomic profiling for the identification of serum diagnostic biomarkers for abdominaland thoracic aortic aneurysms. Proteome Sci. 11, article 27, 13 pages, 2013.
松本健一．
大動脈弁石灰化と細胞外マトリックス・テネイシン X. Vascular Medicine, 先端医学社, 9, 83-88, 2013.

3松本健一．
エーラス・ダンロス症候群の原因遺伝子の一つのテネイシン X. 臨床化学, 日本臨
床化学会, 42, 22-29, 2013.

2012（平成 24）年
Matsumoto, K. et al.
Noticeable decreased expression of tenascin-X in calcific aortic valves. Connect. TissueRes. 53, 460-468, 2012.
Oda, T. et al.
Hypothermia produces rat liver proteomic changes as in hibernating mammals but
decreases endoplasmic reticulum chaperones. Cryobiology 65,104-112, 2012.
Matsumoto, K. et al.
Proteomic analysis of calcified abdominal and thoracic aortic aneurysms. Int. J. Mol. Med.
30, 417-429, 2012.
Matsumoto, K.
Phosphorylation of extracellular matrix tenascin-X detected by differential mass tagging
followed by nanoLC-MALDI-TOF/TOF-MS/MS using ProteinPilot software. Connect.
Tissue Res. 53, 106-116, 2012.

2011（平成 23）年
Kawakami, K. et al.
Behavioral alterations in mice lacking the gene for tenascin-X. Biol. Pharm. Bull. 34,590-593, 2011.

4

2010（平成 22）年
Kii I. et al.
Incorporation of tenascin-C into the extracellular matrix by periostin underlines anextracellular meshwork architecture. J. Biol. Chem. 285, 2028-2039, 2010.
Satoh, K et al.
Increased expression of tenascin-X in thoracic and abdominal aortic aneurysm tissues. Biol.
Pharm. Bull. 33, 1898-1902, 2010.

2009（平成 21）年
Endo, T. et al.
Truncated form of tenascin-X, XB-S, interacts with mitotic motor kinesin Eg5. Mol. Cell.
Biochem. 320, 53-66, 2009.
Fujie, S. et al.
Tenascin-X induces cell detachment through p38 mitogen-activated protein kinase
activation. Biol. Pharm. Bull. 32, 1795-1799, 2009.
Ishitsuka, T. et al. Serum tenascin-X strongly binds to vascular endothelial growth factor.
Biol. Pharm. Bull. 32, 1004-1011, 2009.

2008（平成 20）年
Kato, A. et al.
Induction of truncated form of tenascin-X (XB-S) through dissociation of HDAC1 fromSP-1/HDAC1 complex in response to hypoxic conditions. Exp. Cell Res. 314, 2661-2673,2008.
Tsuboi, Y. et al.
5

DJ-1, a causative gene product of a familial form of Parkinson’s disease, is secreted
through microdomains. FEBS Lett. 582, 2643-2649, 2008.
松本健一．
細胞外マトリックス・テネイシン X によるトリグリセリド合成とその脂肪酸組成の制御機構．生体の科学，医学書院, 59, 209-216, 2008.

6